Quarter Ended Jun 30, 2025
Net sales were up 4% to $114.8 million compared to $110.6 million (up 2% in constant currency).
GAAP net income attributable to common shareholders was $5.3 million, or $0.28 per diluted common share, compared to $1.3 million, or $0.07 per diluted common share.
Adjusted EBITDA was up 8% to $11.3 million compared to $10.4 million.
Source: Q2 2025 Earnings Release
For complete information regarding our financials, see our periodic filings.